IDH1 and glioblastoma: PD-L1 expression has been correlated with histological subtypes in GBM, in particular with the Isocitrate dehydrogenase 1 (IDH1) status.16 Various other mechanisms in the GBM microenvironment contribute to the tumor-induced immune suppression,17 suggesting that effective antitumor therapy requires targeting from multiple angles.